MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Friday reported a loss of $2 million in its first quarter.
On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 10 cents.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.
The specialty pharmaceutical company posted revenue of $25.1 million in the period, which also topped Street forecasts. Four analysts surveyed by Zacks expected $20.5 million.
Recro Pharma shares have risen 24% since the beginning of the year. The stock has fallen 20% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REPH at https://www.zacks.com/ap/REPH